ConductScience.org, home

Paper33201699

Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for Discovering Viral Entry/Release Inhibitors from Nature?

Li H and 4 others. J Med Chem, 2020. Cited by 30 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for Discovering Viral Entry/Release Inhibitors from Nature? Papers, record 33201699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33201699

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for Discovering Viral Entry/Release Inhibitors from Nature?
PubMed
Journal
J Med Chem
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.77
iCite
Revised in PubMed
2021-01-22
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li HHaiwei
2Sun JJiaqi
3Xiao SSulonghttps://orcid.org/0000-0002-6852-9504
4Zhang LLihe
5Zhou DDemin

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
RNA VirusesMajor topic
TriterpenesMajor topic
Virus InternalizationMajor topic
Virus ReleaseMajor topic
Animals
Cell Line, Tumor
Humans
Molecular Structure
SARS-CoV-2
Structure-Activity Relationship
Virus Shedding

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42435079Novel mercapto conjugates of oleanolic acid as potential antifungal agents.Arch Microbiol2026https://conductscience.org/library/papers/42435079PubMed
41912781Exploring bacterial cytochrome P450s for selective activation of aliphatic C-H bonds in pentacyclic triterpenoids.Nat Chem2026https://conductscience.org/library/papers/41912781PubMed
41599373The Emerging Promise of Pentacyclic Triterpenoid Derivatives as Novel Antiviral Agents Against SARS-CoV-2 Variants.Molecules2026https://conductscience.org/library/papers/41599373PubMed
41154696Natural Compounds with Antiviral Activity Against Clinically Relevant RNA Viruses: Advances of the Last Decade.Biomolecules2025https://conductscience.org/library/papers/41154696PubMed
39628461Design and synthesis of betulinic acid-dithiocarbamate conjugates as potential antifungal agents against Candida albicans.RSC Adv2024https://conductscience.org/library/papers/39628461PubMed
39065609In Silico and In Vitro Studies of Terpenes from the Fabaceae Family Using the Phenotypic Screening Model against the SARS-CoV-2 Virus.Pharmaceutics2024https://conductscience.org/library/papers/39065609PubMed
38276760Triterpenoidal Saponins from the Leaves of Aster koraiensis Offer Inhibitory Activities against SARS-CoV-2.Plants (Basel)2024https://conductscience.org/library/papers/38276760PubMed
38067489Friedelin: Structure, Biosynthesis, Extraction, and Its Potential Health Impact.Molecules2023https://conductscience.org/library/papers/38067489PubMed
37367540Transcriptome and Metabolome Integration Reveals the Impact of Fungal Elicitors on Triterpene Accumulation in Sanghuangporus sanghuang.J Fungi (Basel)2023https://conductscience.org/library/papers/37367540PubMed
36903578Triterpene Derivatives as Potential Inhibitors of the RBD Spike Protein from SARS-CoV-2: An In Silico Approach.Molecules2023https://conductscience.org/library/papers/36903578PubMed
36851106Phytoestrogen β-Sitosterol Exhibits Potent In Vitro Antiviral Activity against Influenza A Viruses.Vaccines (Basel)2023https://conductscience.org/library/papers/36851106PubMed
36674943Anti-HIV Potential of Beesioside I Derivatives as Maturation Inhibitors: Synthesis, 3D-QSAR, Molecular Docking and Molecular Dynamics Simulations.Int J Mol Sci2023https://conductscience.org/library/papers/36674943PubMed
36297280Recent Advances in Antiviral Activities of Triterpenoids.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36297280PubMed
35646545A clickable photoaffinity probe of betulinic acid identifies tropomyosin as a target.Acta Pharm Sin B2022https://conductscience.org/library/papers/35646545PubMed
35283698Anti-viral triterpenes: a review.Phytochem Rev2022https://conductscience.org/library/papers/35283698PubMed
35116174Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection.J Adv Res2022https://conductscience.org/library/papers/35116174PubMed
34953146Antiviral plant-derived natural products to combat RNA viruses: Targets throughout the viral life cycle.Lett Appl Microbiol2022https://conductscience.org/library/papers/34953146PubMed
33946174Fluorescence Correlation Spectroscopy Analysis of Effect of Molecular Crowding on Self-Assembly of β-Annulus Peptide into Artificial Viral Capsid.Int J Mol Sci2021https://conductscience.org/library/papers/33946174PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33201699

GET https://conductscience.org/api/papers/v1/33201699/authors